Article Text
Summary
Thionamides, such as methimazole and propylthiouracil, are used for the management of hyperthyroidism. Agranulocytosis is a rare adverse effect of thionamides and elderly patients are especially vulnerable. Here we discuss a case of an 80-year-old woman who developed agranulocytosis and pneumonia approximately 4 weeks after starting low dose methimazole therapy. Despite aggressive treatment with broad-spectrum antibiotics and granulocyte colony stimulating factor, she developed multiorgan failure and died. Our goals are to identify risk factors common to elderly patients and hopefully improve outcomes in this population when prescribed thionamides.
- drugs and medicines
- general guidance on prescribing
- haematology (drugs and medicines)
- thyroid disease
Statistics from Altmetric.com
Footnotes
Contributors All authors made substantial contribution to the conception, design and revision of the draft. SB and VM reviewed all the clinical data, compiled it as a case report, reviewed the literature and were responsible for obtaining the radiological and haematological images. MK and NK helped in gathering patient's data as well as got the consent form.
Competing interests None declared.
Patient consent Obtained.
Provenance and peer review Not commissioned; externally peer reviewed.